ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC

PrivateCIK: 1917529
Location

CAMBRIDGE, MA

πŸ“‹ What this filing means

ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC filed this quarterly 13F‑HR report disclosing 15 equity positions with a total reported market value of $645.63M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.

15
Positions
$645.63M
Total AUM (reported)
69.19M
Total Shares

Allocation by class

TOTAL AUM$645.63M15 positions
COMMON STOCK$645.63M100.0%

Portfolio Concentration

Top 348.2%4–1046.4%11–255.5%TOP 1094.5%0%100%
Top 3$310.90M48.2%
4–10$299.27M46.4%
11–25$35.45M5.5%

Top 3 weight

48.2%

Top 10 weight

94.5%

Voting Authority Distribution

Total shares with voting rights: 69.19M

Sole

Full voting authority

69.19M

shares

% of voting shares100.0%
Shared

Joint voting authority

0.00

shares

% of voting shares0.0%
None

No voting authority

0.00

shares

% of voting shares0.0%

Investment Discretion (by position count)

Sole15
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings15
Rows:

Disc Medicine, Inc.

SOLE
Common Stock
Shares2.75M
TypeSH
Market value$128.98M
19.98%
Sole
2.75M
Shared
0.00
None
0.00

Day One Biopharmaceuticals, Inc.

SOLE
Common Stock
Shares7.61M
TypeSH
Market value$93.35M
14.46%
Sole
7.61M
Shared
0.00
None
0.00

Dyne Therapeutics, Inc.

SOLE
Common Stock
Shares9.89M
TypeSH
Market value$88.57M
13.72%
Sole
9.89M
Shared
0.00
None
0.00

Kymera Therapeutics, Inc.

SOLE
Common Stock
Shares5.86M
TypeSH
Market value$81.43M
12.61%
Sole
5.86M
Shared
0.00
None
0.00

Third Harmonic Bio, Inc.

SOLE
Common Stock
Shares10.91M
TypeSH
Market value$69.70M
10.80%
Sole
10.91M
Shared
0.00
None
0.00

Replimune Group, Inc.

SOLE
Common Stock
Shares2.10M
TypeSH
Market value$35.90M
5.56%
Sole
2.10M
Shared
0.00
None
0.00

Vigil Neuroscience, Inc.

SOLE
Common Stock
Shares5.84M
TypeSH
Market value$31.46M
4.87%
Sole
5.84M
Shared
0.00
None
0.00

Generation Bio, Co.

SOLE
Common Stock
Shares8.28M
TypeSH
Market value$31.38M
4.86%
Sole
8.28M
Shared
0.00
None
0.00

Aerovate Therapeutics, Inc.

SOLE
Common Stock
Shares2.04M
TypeSH
Market value$27.67M
4.29%
Sole
2.04M
Shared
0.00
None
0.00

Ikena Oncology, Inc.

SOLE
Common Stock
Shares5.02M
TypeSH
Market value$21.73M
3.37%
Sole
5.02M
Shared
0.00
None
0.00

Akero Therapeutics, Inc.

SOLE
Common Stock
Shares359.25K
TypeSH
Market value$18.17M
2.81%
Sole
359.25K
Shared
0.00
None
0.00

AvroBio, Inc.

SOLE
Common Stock
Shares4.54M
TypeSH
Market value$6.99M
1.08%
Sole
4.54M
Shared
0.00
None
0.00

Xilio Therapeutics, Inc.

SOLE
Common Stock
Shares2.76M
TypeSH
Market value$5.82M
0.90%
Sole
2.76M
Shared
0.00
None
0.00

Dianthus Therapeutics, Inc.

SOLE
Common Stock
Shares236.98K
TypeSH
Market value$3.24M
0.50%
Sole
236.98K
Shared
0.00
None
0.00

Spero Therapeutics, Inc.

SOLE
Common Stock
Shares1.01M
TypeSH
Market value$1.23M
0.19%
Sole
1.01M
Shared
0.00
None
0.00
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC 13F Holdings β€” 15 Positions | Finecho